Edwards Lifesciences Corp (EW): Shares Outstanding

Annual figures by period end, from SEC filings.

Stock splits: 2-for-1, first reflected in a filing dated 2016-02-19; 3-for-1, first reflected in a filing dated 2020-07-27. Figures are as filed: per-share figures and share counts last reported before a split are on the old share basis, so changes and growth rates across a split are not shown. Splits are read from the filings' own restatements, so a share conversion in a merger or reorganization shows up the same way.

580.70M

As of 2025-12-31

576.60M

As of 2026-06-30

-1.5%

3-year compound annual growth

-1.4%

5-year compound annual growth

2009-12-31 Shares Outstanding (shares) 2025-12-31

Paler bars were last filed before a stock split, on the old share basis.

Period ended	Shares Outstanding	Change YoY	Source filing
2025-12-31	580.70M	-1.3%	2026-02-25, Balance as of period end
2024-12-31	588.60M	-2.1%	2026-02-25, Balance as of period end
2023-12-31	601.10M	-1.2%	2025-02-28, Balance as of period end
2022-12-31	608.30M	-2.5%	2024-02-12, Balance as of period end
2021-12-31	624.10M	0.0%	2023-02-13, Balance as of period end
2020-12-31	624.30M	n/c	2022-02-14, Balance as of period end
2019-12-31	209.10M	n/c	2021-02-12, Balance as of period end
2018-12-31	207.70M	-1.0%	2020-02-14, Balance as of period end
2017-12-31	209.70M	-0.9%	2019-02-15, Balance as of period end
2016-12-31	211.60M	-1.8%	2018-02-16, Balance as of period end
2015-12-31	215.40M	n/c	2017-02-17, Balance as of period end
2014-12-31	107.80M	n/c	2016-02-19, Balance as of period end
2013-12-31	109.30M	-4.4%	2015-02-20, Balance as of period end
2012-12-31	114.30M	+0.2%	2014-02-28, Balance as of period end
2011-12-31	114.10M	-0.8%	2013-02-28, Balance as of period end
2010-12-31	115.00M	n/c	2012-02-27, Balance as of period end
2009-12-31	56.80M	n/a	2011-02-28, Balance as of period end